EPICS THERAPEUTICS is developing first-in-class drugs in oncology based on RNA epigenetics. The company focuses on discovery and development of small molecule inhibitors of RNA-modifying enzymes to treat cancer.
Location: Belgium, Hainaut, Charleroi
Investors 5
| Date | Name | Website |
| - | Newton Bio... | newtonbioc... |
| - | Fund+ | fundplus.b... |
| - | Le Groupe ... | sriw.be |
| - | SPDG | spdg.be |
| - | SFPIM | sfpim.be |